Solventum Deal History & Licensing Activity
Solventum is a life sciences. Over the past three years, Solventum has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals). The company currently has 8 active clinical trials, primarily in Dermatology.
Deals (12mo)
1
Active Trials
8
Top Modality
Other
Focus Area
Dermatology
Solventum Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Solventum in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| wound care products | Acera Surgical | Other | Unknown | acquisition | Nov 2025 |
Solventum Pipeline Focus
Therapeutic areas and modalities where Solventum is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Solventum Strategic Signals
Key indicators of Solventum's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Solventum Clinical Pipeline
Solventum has 8 active clinical trials across 2 development phases.
7
Not Applicable
1
Phase 2
See How Your Asset Matches Solventum's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Solventum Licensing & Deal Activity
Solventum is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Solventum ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Solventum include Dermatology (2 deals and trials), and Solid Tumors (2 deals and trials). In terms of modality, Solventum has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Solventum and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Solventum's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.